Marinol and affect lability Patient Reports February 11, 2012

Marinol Side Effects Report #5083150-9
Marinol side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2003. Female patient, 48 years of age, weighting 163.1 lb, was diagnosed with muscle spasticity, multiple sclerosis  and was treated with Marinol. After drug was administered, patient experienced the following side effects: affect lability, asthenia, urinary tract infection . Marinol dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient was hospitalized. Patient recovered.

Marinol Side Effects Report #5430601-3
Marinol side effect was reported by a Consumer or non-health professional from CANADA on Aug 20, 2007. Female patient was diagnosed with hypogeusia, depression , thrombosis, pneumonia , ill-defined disorder, hypothyroidism and was treated with Marinol. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, affect lability, anorexia, anxiety , atrial fibrillation , autonomic nervous system imbalance, bronchial obstruction, chromaturia. Marinol dosage: DAILY DOSE: 5 MILLIGRAM(S). During the same period patient was treated with VENLAFAXINE, ENOXAPARIN, LEVOFLOXACIN, METRONIDAZOLE, VENTOLIN, LEVOTHYROXINE. Patient died on 07/28/2007.